ELI LILLY & Co is 33.4x more valuable than BeOne Medicines AG by market capitalization ($1.072 T vs $32.14 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ONC | LLY |
|---|---|---|
| Market cap | $32.14 B | $1.072 T |
| US-listed rank | #444 | #10 |
| Revenue (latest FY) | $5.34B | $65.18B |
| Net income (latest FY) | $286.93M | $20.64B |
| Net margin | 5.4% | 31.7% |
| P/E (trailing FY) | 112.0 | 51.9 |
| SEC filings | 1,167 | 989 |
ELI LILLY & Co is 33.4x more valuable than BeOne Medicines AG by market capitalization ($1.072 T vs $32.14 B).
In their latest fiscal years, BeOne Medicines AG reported $5.34B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: BeOne Medicines AG and ELI LILLY & Co, or browse the full rankings.